Drug Approval | September 29, 2023
Kivo’s expanded platform brings compliant collaboration and intelligent process automation to emerging Regulatory, Clinical and Quality teams
Mankind Pharma commences the commercial operations newly set-up plant in Udaipur
Reinforces Henkel commitment to supporting customers and ecosystem in medical healthcare
The company has received the Establishment Inspection Report (EIR) from the USFDA for the Pre-Approval Inspection (PAI) at a manufacturing site situated at Savli, Vadodara, Gujarat, with Zero 483 observations
In 2030 over 50% of FDA approvals will involve AI discovered and developed drugs
The inspection classification was determined by the agency as Voluntary Action Indicated
Amgen will be prohibited from leveraging its drug portfolio to disadvantage rivals and will be required to seek prior approval before acquiring related products
This approval has come from the company's finished dosage form manufacturing facility
Granules India received approval from Brazilian Health Regulatory Agency ANVISA
Subscribe To Our Newsletter & Stay Updated
